Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;2(2):436-82.
doi: 10.3390/cancers2020436.

Molecular mechanisms of mouse skin tumor promotion

Joyce E Rundhaug  1 , Susan M Fischer
Affiliations

Molecular mechanisms of mouse skin tumor promotion

Joyce E Rundhaug et al. Cancers (Basel). 2010.

Abstract

Multiple molecular mechanisms are involved in the promotion of skin carcinogenesis. Induction of sustained proliferation and epidermal hyperplasia by direct activation of mitotic signaling pathways or indirectly in response to chronic wounding and/or inflammation, or due to a block in terminal differentiation or resistance to apoptosis is necessary to allow clonal expansion of initiated cells with DNA mutations to form skin tumors. The mitotic pathways include activation of epidermal growth factor receptor and Ras/Raf/mitogen-activated protein kinase signaling. Chronic inflammation results in inflammatory cell secretion of growth factors and cytokines such as tumor necrosis factor-a and interleukins, as well as production of reactive oxygen species, all of which can stimulate proliferation. Persistent activation of these pathways leads to tumor promotion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multistage mouse skin carcinogenesis model.
Figure 2
Figure 2
Growth factor signaling pathways important in tumor promotion. Epidermal growth factor (EGF) and other ligands of the EGF receptor (EGFR)/ErbB family of receptors, including transforming growth factor-α (TGFα), amphiregulin, heparin-binding EGF-like growth factor (HB-EGF) and betacellulin, activate signaling of both the Ras/Raf/mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK and phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways. Insulin-like growth factor-1 (IGF-1) signals through its receptor IGF1R, which phosphorylates insulin receptor substrate-1 (IRS1) and SH2-containing protein (Shc) as well as other substrates leading to the activation of both Ras/Raf/MAPK and PI3K/Akt/mTOR pathways. Members of the transforming growth factor-β (TGFβ) family (TGFβ1, TGFβ2 and TGFβ3) bind to TGFβ receptor type II (TβRII) causing the recruitment of the type I receptor (TβRI), which phosphorylates Smad2 and Smad3 allowing them to form a complex with Smad4 that then translocates to the nucleus to modulate gene expression.
Figure 3
Figure 3
Cytokine signaling pathways important in tumor promotion.
Figure 4
Figure 4
Cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) signaling in tumor promotion.
See this image and copyright information in PMC

References

    1. DiGiovanni J. Multistage skin carcinogenesis in mice. In: Waalkes M.P., Ward J.M., editors. Carcinogenesis. Raven Press; New York, NY, USA: 1994. pp. 265–299.
    1. Tharappel J.C., Lee E.Y., Robertson L.W., Spear B.T., Glauert H.P. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 2002;179:172–184. - PubMed
    1. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211–217. doi: 10.1016/j.ccr.2005.02.013. - DOI - PubMed
    1. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006;97:439–447. - PMC - PubMed
    1. Mueller M.M. Inflammation in epithelial skin tumours: Old stories and new ideas. Eur. J. Cancer. 2006;42:735–744. - PubMed

LinkOut - more resources